
Dexcom
Chronic Disease Management & Digital Therapeutics
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management, providing real-time glucose readings.
About Dexcom
Dexcom is a global leader in continuous glucose monitoring, providing real-time glucose data and AI-powered insights for diabetes management.
Leadership Team
Key executives and founders sourced from public LinkedIn profiles.
Experienced Chief Audit Executive reporting to the Board of Directors with experience in Sarbanes Oxley, Compliance, Financial, Operational and Information Technology Audits. Certifications include: Certified Public Accountant, Certified Information Systems Auditor
Matt Dolan, Northwestern graduate, is currently a Senior Vice President, General Manager of New Markets with a demonstrated history of working in the medical device industry. Matt is a strong business development professional skilled in Corporate Development, Hedge Funds, Valuation, Due Diligence, and Business Strategy.
I am positive leader with proven experience influencing and championing a culture of innovation, talent development, global collaboration, operational excellence, lean manufacturing and six sigma. Leadership is privilege and a blessing – It carries with the responsibility to inspire others to succeed #DiversityEquityAndInclusion, #DiversityInSTEAM, #WomenInTech, #WomenInSTEAM, #WomenInScience #Latinx Specialties: Operational Excellence Culture, Strategic Planning, People Development, ISO 13485 SME, FDA QSR AAMI Certified, FDA Class III Devices SME, New Product Introduction Excellence, Manufacturing Process Transferring, Manufacturing Technology Road-mapping, Process Validation, Process Performance Problem Solving, Process Improvement, Automation Design for Six Sigma, Design for Manufacturability, Process Development, Asset Management Excellence
Experienced Finance Executive with a demonstrated history of working in both the medical device and biotech industry. Skilled in multiple areas of finance, from public facing Investor Relations and Capital Markets to internal facing including Organizational Development, Infrastructure Design on both a human capital and systems perspective, Business Partnership, M&A, Technical Acumen on both financial, accounting and taxation matters, Revenue Recognition, Business Process Improvement, Auditing, Variance Analysis, and Financial Analysis. Strong finance professional with a long history of successful outcomes across multiple aggressive organizations and a skilled technical background and training.
Mission & Approach
Mission
“Dexcom empowers people to take control of health through innovative glucose biosensing technology.”
AI Approach
predictive analytics
Founding Story
Since 1999, Dexcom has been developing innovative technology that has transformed how people manage diabetes and track their glucose. The company has set the standard in glucose biosensing for 25 years and counting.
Products & Solutions
Dexcom Clarity
platformData analysis and reporting platform for glucose monitoring
Dexcom Clarity is a data platform that provides analysis and reporting capabilities for continuous glucose monitoring data, helping users and healthcare providers understand glucose patterns and trends over time.
Dexcom Follow
softwareCompanion app for remote glucose monitoring
Dexcom Follow is a companion application that allows designated followers to remotely monitor a Dexcom user's glucose levels in real-time, providing peace of mind for caregivers and family members.
Dexcom Share
softwareRemote glucose monitoring and sharing platform
Dexcom Share enables users to share their real-time glucose data with family members, caregivers, or healthcare providers remotely, allowing for better support and monitoring.
Stelo Glucose Biosensor
FlagshipdeviceFirst over-the-counter CGM for personalized glucose insights without prescription
Stelo is an over-the-counter integrated Continuous Glucose Monitor for people 18+ not on insulin. It sends personal glucose insights to your phone, helping users understand how lifestyle, diet, and exercise impact glucose levels. No prescription required, no fingersticks needed.
Dexcom G7 15 Day
FlagshipdeviceExtended 15-day wear continuous glucose monitoring system
Extended version of Dexcom G7 with 15-day sensor life (73.9% of sensors last the full 15 days). Delivers the same proven results with best-in-class accuracy and real-time glucose monitoring to phone or receiver.
Dexcom G7
FlagshipdeviceThe world's most powerful CGM system with best-in-class accuracy
Dexcom G7 is a continuous glucose monitoring system designed for all types of diabetes. It sends glucose numbers to your phone or receiver in real time every 5 minutes, helping users better control diabetes. Features best-in-class accuracy and a growing ecosystem of connected partners including insulin pumps, pens, AID algorithms, and digital health apps.
Customer Success Stories
Lance Bass (Celebrity User)
other
Personal diabetes management with continuous glucose monitoring
Hiring Activity
View Open Roles →Product & Market
Product Stage
enterprisePrimary Market
consumersCompany Details
- Founded
- 1999
- Headquarters
- San Diego, CA, USA
- Employees
- 10001
- Stage
- public
- Profile last updated
- June 22, 2026
Official Sources
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingDexcom in the News
All News →Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.
